Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions

Bibliography

• Martin WR, Eades CG, Thompson JA, The effects of morphine and morphine-like drugs in nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976;197:517-32
   PubMed Web of Science ®Google Scholar
• Matsumoto RR, Liu Y, Lerner M, Sigma receptors: potential medications development target for anti-cocaine agents. Eur J Pharmacol 2003;469:1-12
   PubMed Web of Science ®Google Scholar
• Maurice T, Martin-Fardon R, Romieu P, Matsumoto RR. Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev 2002;26:499-527
   PubMed Web of Science ®Google Scholar
• Aram JA, Martin D, Tomezyk M, Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J Pharmacol Exp Ther 1989;248:320-8
   PubMed Web of Science ®Google Scholar
• Martin BR, Katzen JS, Woods JA, Stereoisomers of [3H]-N-allylnormetazocine bind to different sties in mouse brain. J Pharmacol Exp Ther 1984;231(3):539-44
   PubMed Web of Science ®Google Scholar
• Ela C, Barg J, Vogel Z, Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 1994;269:1300-9
   PubMed Web of Science ®Google Scholar
• Novakova M, Ela C, Barg J, Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats. Eur J Pharmacol 1995;286:19-30
   PubMed Web of Science ®Google Scholar
• Novakova M, Ela C, Bowen WD, Highly selective sigma receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes. Eur J Pharmacol 1998;353:315-27
   PubMed Web of Science ®Google Scholar
• Ela C, Hasin Y, Eilam Y. Apparent desensitization of a sigma receptor sub-population in neonatal rat cardiac myocytes by pre-treatment with sigma receptor ligands. Eur J Pharmacol 1996;295:275-80
   PubMed Web of Science ®Google Scholar
• Novokova M, Bruderova V, Sulova Z, Modulation of expression of the sigma receptors in the heart of rat and mouse in normal and pathological conditions. Gen Physiol Biophys 2007;26:110-17
   PubMed Web of Science ®Google Scholar
• Fialova K, Krizanova O, Jarkovsky J, Novakova M. Apparent desensitization of the effects of sigma receptor ligand haloperidol in isolated rat and guinea pig hearts after chronic treatment. Can J Physiol Pharmacol 2009;87:1019-27
   PubMed Web of Science ®Google Scholar
• Hellewell SB, Bruce A, Feinstein G, Rat liver and kidney contain high densities of sigma1 and sigma2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 1994;268:9-18
   PubMed Web of Science ®Google Scholar
• Maurice T, Gregoire C, Espallergues J. Neuro(active)steroids actions at the neuromodulatory sigma1 (σ1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav 2006;84:581-97
   PubMed Web of Science ®Google Scholar
• Bhuiyan MS, Fukunaga K. Stimulation of sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats. Expert Opin Ther Targets 2009;13:1253-65
   PubMed Web of Science ®Google Scholar
• Bhuiyan MS, Fukunaga K. Stimulation of sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats. Exp Biol Med 2010;235:356-64
   Web of Science ®Google Scholar
• Bhuiyan MS, Tagashira H, Fukunaga K. Dehydroepiandrosterone mediated stimulation of sigma-1 receptor activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. Cardiovasc Ther 2010; published online 11 June 2010, DOI: 10.1111/j.1755-5922.2010.00196.x
   Google Scholar
• Ramamoorthy JD, Ramamoorthy S, Mahesh VB, Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells. Endocrinology 1995;136:924-32
   PubMed Web of Science ®Google Scholar
• Fontanilla D, Johannessen M, Hajipour AR, The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 2009;323:934-7
   PubMed Web of Science ®Google Scholar
• Baulieu EE. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998;23:963-87
   PubMed Web of Science ®Google Scholar
• Waterhouse RN, Chang RC, Atuahene N, Collier TL. In vitro and in vivo binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPS. Synapse 2007;61(7):540-6
   PubMed Web of Science ®Google Scholar
• Collier TL, Waterhouse RN, Kassiou M. Imaging sigma receptors: applications in drug development. Curr Pharm Des 2007;13:51-72
   PubMed Web of Science ®Google Scholar
• Monnet FP, Maurice T. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. J Pharmacol Sci 2006;100:93-118
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Ishiwata K, Ishii K, High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Biol Psychiatry 2007;62:878-83
   PubMed Web of Science ®Google Scholar
• Taylor CB, Youngblood ME, Catellier D, Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005;62:792-8
   PubMed Web of Science ®Google Scholar
• Narita N, Hashimoto K, Tomitaka S, Minoabe Y. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 1996;307:117-19
   PubMed Web of Science ®Google Scholar
• Bhuiyan MS, Shioda N, Fukunaga K. Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. Am J Physiol Endocrinol Metab 2007;293:E1606-14
   PubMed Web of Science ®Google Scholar
• Bhuiyan MS, Shioda N, Shibuya M, Activation of endothelial nitric oxide synthase by a vanadium compound ameliorates pressure overload-induced cardiac injury in ovariectomized rats. Hypertension 2009;53:57-63
   PubMed Web of Science ®Google Scholar
• Bhuiyan MS, Fukunaga K. Characterization of an animal model of postmenopausal cardiac hypertrophy and novel mechanisms responsible for cardiac decompensation using ovariectomized pressure-overloaded rats. Menopause 2010;17:213-21
   PubMed Web of Science ®Google Scholar
• Shioda N, Yamamoto Y, Watanabe M, Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain. J Neurosci 2010;30(8):3146-55
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 2007;131:596-610
   PubMed Web of Science ®Google Scholar
• Zeng G, Nystrom FH, Ravichandran LV, Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;101:1539-45
   PubMed Web of Science ®Google Scholar
• Dumont M, Lemaire S. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma2 binding sites in rat heart membrane preparations. Eur J Pharmacol 1991;209:245-8
   PubMed Web of Science ®Google Scholar
• Zamanillo D, Andreu F, Ovalle S, Up-regulation of sigma1 receptor mRNA in rat brain by a putative atypical antipsychotic and sigma receptor ligand. Neurosci Lett 2000;282:169-72
   PubMed Web of Science ®Google Scholar
• Shirayama Y, Nishikawa T, Umino A, Takahashi K. p-Chlophenylalanine reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain. Eur J Pharmacol 1993;237:117-26
   PubMed Web of Science ®Google Scholar
• Inoue A, Sugita S, Shoji H, Repeated haloperidol treatment decreases sigma1 receptor binding but does not affect its mRNA levels in the guinea pig or rat brain. Eur J Pharmacol 2000;401:307-16
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Miura R, Yamamoto T, Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding. FEBS Lett 1999;445:19-22
   PubMed Web of Science ®Google Scholar
• Nakano M, Osada K, Misonoo A, Fluvoxamine and sigma-1 receptor agonists dehydroepiandrosterone (DHEA)-sulfate induces the Ser473-phosphorylation of Akt-1 in PC12 cells. Life Sci 2010;86:309-14
   PubMed Web of Science ®Google Scholar
• Spruce BA, Campbell LA, McTavish N, Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res 2004;64:4875-86
   PubMed Web of Science ®Google Scholar
• Wang L, Duncan G. Silencing of sigma-1 receptor induces cell death in human lens cells. Exp Cell Res 2006;312:1439-46
   PubMed Web of Science ®Google Scholar
• Houser SR, Molkentin JD. Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal 2008;1(25):pe31
   PubMed Web of Science ®Google Scholar
• Monnet FP. Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance. Biol Cell 2005;97:873-83
   PubMed Web of Science ®Google Scholar
• Tchedre KT, Huang RQ, Dibas A, Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Invest Ophthalmol Vis Sci 2008;49(11):4993-5002
   PubMed Web of Science ®Google Scholar
• Hayashi T, Rizzuto R, Hajnoczky G, Su TP. MAM: more than just a housekeeper. Trends Cell Biol 2009;19:81-8
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su TP. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci USA 2001;98:491-6
   PubMed Web of Science ®Google Scholar
• Hayashi M, Yamaji Y, Nakazato Y, Saruta T. The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells. Hypertens Res 2000;23:521-5
   PubMed Web of Science ®Google Scholar
• Hashimoto K. Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. Cent Nerv Syst Agents Med Chem 2009;9:197-204
   PubMedGoogle Scholar
• Cooper GL. The safety of fluoxetine: an up-date. Br J Psychiatry 1988;153:77-86
   Web of Science ®Google Scholar
• Fisch C. Effect of fluoxetine on the electrocardiogram. J Clin Psychiatry 1985;46(Suppl 2):42-4
   PubMedGoogle Scholar
• Glassman AH, O'Connor CM, Califf RM, Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9
   PubMed Web of Science ®Google Scholar
• Swenson JR, O'Connor CM, Barton D, Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003;92:1271-6
   PubMed Web of Science ®Google Scholar
• Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation 2005;111:250-3
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Glassman AH, Malinin AI, Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003;108:939-44
   PubMed Web of Science ®Google Scholar
• Shores MM, Pascualy M, Lewis NL, Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology 2001;26:433-9
   PubMed Web of Science ®Google Scholar
• Golding M, Kotlyar M, Carson SW, Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses. Psychopharmacology 2005;182:321-6
   PubMed Web of Science ®Google Scholar
• Golding M, Kotlyar M, Garbutt JC, Paroxetine modulates psychological and sympathetic responses during public speaking. J Clin Psychopharmacol 2002;22:98-9
   PubMed Web of Science ®Google Scholar
• Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 2006;119:113-16
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Gurbel PA, O'Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res 2001;43:453-62
   PubMed Web of Science ®Google Scholar
• Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001;104:1894-8
   PubMed Web of Science ®Google Scholar